| First Author | Hu YT | Year | 2024 |
| Journal | Acta Pharmacol Sin | Volume | 45 |
| Issue | 11 | Pages | 2366-2379 |
| PubMed ID | 38914678 | Mgi Jnum | J:358077 |
| Mgi Id | MGI:7764542 | Doi | 10.1038/s41401-024-01322-8 |
| Citation | Hu YT, et al. (2024) Cystathionine gamma-lyase-derived H(2)S negatively regulates thymic egress via allosteric inhibition of sphingosine-1-phosphate lyase. Acta Pharmacol Sin 45(11):2366-2379 |
| abstractText | Thymic egress is a crucial process for thymocyte maturation, strictly regulated by sphingosine-1-phosphate lyase (S1PL). Recently, cystathionine gamma-lyase (CSE), one of the enzymes producing hydrogen sulfide (H(2)S), has emerged as a vital immune process regulator. However, the molecular connection between CSE, H(2)S and thymic egress remains largely unexplored. In this study, we investigated the regulatory function of CSE in the thymic egress of immune cells. We showed that genetic knockout of CSE or pharmacological inhibition by CSE enzyme inhibitor NSC4056 or D,L-propargylglycine (PAG) significantly enhanced the migration of mature lymphocytes and monocytes from the thymus to the peripheral blood, and this redistribution effect could be reversed by treatment with NaHS, an exogenous donor of H(2)S. In addition, the CSE-generated H(2)S significantly increased the levels of S1P in the peripheral blood, thymus and spleen of mice, suppressed the production of proinflammatory cytokines and rescued pathogen-induced sepsis in cells and in vivo. Notably, H(2)S or polysulfide inhibited S1PL activity in cells and an in vitro purified enzyme assay. We found that this inhibition relied on a newly identified C(203)XC(205) redox motif adjacent to the enzyme's active site, shedding light on the biochemical mechanism of S1PL regulation. In conclusion, this study uncovers a new function and mechanism for CSE-derived H(2)S in thymic egress and provides a potential drug target for treating S1P-related immune diseases. |
